👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVwv3q
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVwv3w
@drtimos.bsky.social
@drtimos.bsky.social👋 CGT and RNA peers, what is the single 90 day challenge blocking you? Share in 60 seconds: http://dlvr.it/TVwv3q
Then join the Gene, Cell and RNA Therapy Strategy Network: http://dlvr.it/TVwv3w
@drtimos.bsky.social🚀 Contributed to FirstWord report on AI in personalized medicine: smarter trials, faster discovery 🧬💊. Early AI drugs show 80–90% Ph 1 success! 🌍 Challenges remain, but partnerships & continuous learning will drive the future. #LucidQuest
Read more 👉 http://dlvr.it/TVwlwY
@drtimos.bsky.socialLucidQuest YouTube > Women’s Health Strategic Roundup: Earlier Intervention | Sept 08 - Oct 13, 2026: The latest edition of the Women’s Health Strategic Roundup, covering developments from 8 September to 13 October 2026, highlights a broader shift toward… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚨 Who’s leading BioPharma (+ Google) CVC in 2025?
🔎 #LucidQuest analyzed 22 CVCs—focus by Tech & Therapy Areas + shifts vs. 2023.
Grab the FREE snapshot ⚡
@drtimos.bsky.socialLucidQuest YouTube > AI in Healthcare Strategic Roundup from September 12 to October 12, 2026: From 12 September to 12 October 2026, healthcare AI increasingly shifted from demonstrating technical performance to proving that solutions can be trusted,… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialYour launch may look great on Google, but AI answers can cite others. #LucidScope tracks perception + answer differences across models and personas, with source tracing and risk flags. Start with an AI Answer Audit: http://dlvr.it/TVtwwG #LucidQuest
@drtimos.bsky.socialZero-click is here: AI summaries decide what gets seen. #LucidScope benchmarks how major models describe you vs competitors, spots outdated or hallucinated claims, and recommends content + schema actions. Request an audit: http://dlvr.it/TVttGb #LucidQuest
@drtimos.bsky.social🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TVtBkt #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII
@drtimos.bsky.social🚀 Big buzz at #ASGCT25: #GeneEditing & #CRISPR headlines, 20% data-driven talk, 85% positive vibes on breakthrough therapies for #DMD & #rarediseases!🧬 Download our full #socialmedia report! http://dlvr.it/TVt82T #GeneTherapy #SocialListening #LucidQuest
@ASGCTherapy @ESGCT
@drtimos.bsky.socialWhat if strategy felt like live chess?
#LucidWargames runs dynamic sims, pits you vs adaptive AI rivals, adjudicates by KPIs, and maps odds with 100+ Monte Carlo runs.
Prep or power your next session with rigor: http://dlvr.it/TVsnLM
Demo: http://dlvr.it/TVsnLT
#LucidQuest
@drtimos.bsky.socialFrom slides to simulations. #LucidWargames, a multi-agent engine, pressure tests strategy with evolving scenarios, objective scoring, and probability maps from 100+ Monte Carlo runs. Optimize your next workshop: http://dlvr.it/TVsdpy Demo: http://dlvr.it/TVsdpz #LucidQuest
@drtimos.bsky.social🚀 Dive into #ASCOGU25 buzz!
Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.
#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺
Download our full report http://dlvr.it/TVsc9b !
@drtimos.bsky.socialStay ahead in healthcare innovation.
Subscribe to #LucidQuest's Weekly LQ AI Report for #AI breakthroughs, #PrecisionMedicine insights & #DigitalHealth trends.
Get tips & success stories delivered to your inbox. http://dlvr.it/TVsMfH
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVs6b9
@ASCO
#SocialListening #LucidQuest
@drtimos.bsky.social#LucidQuest helps Pharma/Biotech/HealthTech teams turn market signals into decisions, fast.
Start with #QuickAnswers (rapid primary + secondary CI), scale to deeper projects, conference coverage, #LucidWargames simulations, #LucidScope AI narrative audits, and #NexusBrain insight capture.
@drtimos.bsky.social🔥 Hot therapy areas: Oncology, CNS, Rare Diseases.
Legacy tech & slow-growth areas decline.
💡 Reassess your CVC portfolio now!
📥 Full report: http://dlvr.it/TVrf7K | 📧 Talk to experts: [email protected]
#PharmaCVC #LifeSciences #HealthcareInnovation #LucidQuest
@drtimos.bsky.socialLucidQuest YouTube > Gene & Cell Therapy Strategic Roundup | September 1 - October 6, 2026: From 1 September to 6 October 2026, gene and cell therapy developments signaled a shift from technology validation toward proving durable, safe and commercially… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.socialLucidQuest YouTube > Respiratory Strategic Roundup: Earlier Intervention | Sep 04—Oct 07, 2026: The latest edition of the Respiratory Strategic Roundup, covering developments from September 4 to October 7, 2026, highlights a broader shift in respiratory… Subscribe for more! #LucidQuest #PharmaCI
@drtimos.bsky.social🚀 Conference coverage to #CGT strategy. #LucidQuest turns congress signals into structured intel: what changed, who it affects, next steps for teams and investors. Previews, recaps, KOLs, CI tracking, decision-ready outputs. 📩 [email protected]
@drtimos.bsky.socialHow to win in #Oncology and #Hematology in 2025
📥 Get a FREE #LucidQuest Report http://dlvr.it/TVqzpq
🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.
🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.